전체 프로그램

CGTLimited DatastaleSumithira VasuPhase 1

Anti-CD19/CD20/CD22 CAR T-Cells (Anti-CD19/CD20/CD22 CAR T-Cells)

Recurrent Acute Lymphoblastic Leukemia; Recurrent B Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4

CGTLimited DatastalePromiCell Therapeutics, Inc.Phase 2

Anti-STEAP1 CAR T-cells (Anti-STEAP1 CAR T-cells)

Metastatic Castration-Resistant Prostate Carcinoma; Metastatic Prostate Adenocarcinoma · MET

#MET#CGT#Phase2#cell-gene-therapy#CAR-T+4

CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

Anti-Tumor Necrosis Factor (TNF, Anti-Tumor Necrosis Factor, Anti-Tumor Necrosis Factor (TNF) Receptor Superfamily Member 8 (CD30) Chimeric Antigen Receptor (CAR) T cells)

Lymphoma, Large-Cell, Anaplastic; Enteropathy-Associated T-Cell Lymphoma · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+5

CGTLimited DatastaleRoswell Park Cancer InstitutePhase 1

Autologous Anti-CD83 CAR T-cells (Autologous Anti-CD83 CAR T-cells)

Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

Autologous CCR4 CAR T cells (Autologous CCR4 CAR T cells)

Relapsed and/or Refractory Mature T Cell Malignancy; Peripheral T-Cell Lymphoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5

CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

Autologous CD5 CAR T-cells (Autologous CD5 CAR T-cells)

T-Cell Acute Lymphocytic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · FRα

CGTLimited DatastaleBaylor College of MedicinePhase 1

Autologous CD5.CAR/28zeta CAR T cells (Autologous CD5.CAR/28zeta CAR T cells)

T-cell Acute Lymphoblastic Lymphoma; T-non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Lymphoma

#T-cellAcuteLymphoblasticLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3

CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

Autologous CD7 CAR T-cell (Autologous CD7 CAR T-cell)

T-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · FRα

CGTLimited DatastaleZhejiang UniversityPhase 1

BCMA Targeted CAR T-cells (BCMA Targeted CAR T-cells)

Relapse Multiple Myeloma; Refractory Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+4

CGTLimited DatastaleCells & Genes Biotech (Shanghai…Phase 1

BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell (BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell)

Relapsed/Refractory; Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+5

ADCLimited DatastaleSeagenPreclinical

brentuximab vedotin (Adcetris, Brentuximab Vedotin Plus CHP)

CD30-Positive Peripheral T-Cell Lymphoma · CD30

#CD30#ADC#Preclinical#antibody-drug-conjugate#CD30-PositivePeripheralT-CellLym+1

CGTLimited DatastaleGroupe Hospitalier Pitie-Salpet…Preclinical

CAR T-cell and Cellular Therapies (CAR T-cell and Cellular Therapies)

Adverse Drug Reactions; Cancer · Adverse Drug Reactions

#AdverseDrugReactions#CGT#Preclinical#cell-gene-therapy#CAR-T+3

CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 1

CAR-CLDN18.2 T-Cells (CAR-CLDN18.2 T-Cells)

Advanced Solid Tumor · CLDN18.2

#CLDN182#CGT#Phase1#cell-gene-therapy#CAR-T+3

CGTLimited DatastaleUniversity College, LondonPhase 1

CAR19 T-Cells (CAR19 T-Cells)

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2

CGTLimited DatastaleGyala TherapeuticsPhase 2

CART84 (CART84)

Acute Myeloblastic Leukaemia; Leukemia, T-Cell · Acute Myeloblastic Leukaemia

#AcuteMyeloblasticLeukaemia#CGT#Phase2#cell-gene-therapy#CAR-T+4

CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

CD117 CAR T-cells (CD117 CAR T-cells)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2

CGTLimited DatastalePeking University People's Hosp…Phase 1

CD147- CAR T cells (CD147- CAR T cells)

T-cell Non-Hodgkin's Lymphoma · T-cell Non-Hodgkin's Lymphoma

#T-cellNon-HodgkinsLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2

CGTLimited DatastaleGuangdong Zhaotai Cell Bio-tech…Phase 2

CAT19T2 (CD19 CAR T-Cell, CD19 CAR T-Cell(CAT19T2))

B-cell Acute Lymphoblastic Leukemia; B-Cell Lymphoma, Unspecified · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+5

Trials 1Status Discontinued

CGTLimited DatastaleThird Military Medical Universi…Phase 1

CD19 CAR and PD-1 knock out engineered T-cells (CD19 CAR and PD-1 knock out engineered T-cells)

Acute Lymphoblastic Leukemia; Burkitt Lymphoma · PD-1

#PD-1#CGT#Phase1#cell-gene-therapy#CAR-T+4

CGTLimited DatastaleBaylor College of MedicinePhase 1

3 / 6 pages

← Previous Next →

다음 갱신 D-5 · 마지막 9월 2일 · 방문 1,097 / 70,931

Biologic만FDA만

Allogeneic CD5.CAR/28zeta CAR T cells (Allogeneic CD5.CAR/28zeta CAR T cells)

T-cell Acute Lymphoblastic Lymphoma; T-non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Lymphoma

#T-cellAcuteLymphoblasticLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3

CGTLimited DatastaleSumithira VasuPhase 1

Anti-CD19/CD20/CD22 CAR T-Cells (Anti-CD19/CD20/CD22 CAR T-Cells)

Recurrent Acute Lymphoblastic Leukemia; Recurrent B Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4

CGTLimited DatastalePromiCell Therapeutics, Inc.Phase 2

Anti-STEAP1 CAR T-cells (Anti-STEAP1 CAR T-cells)

Metastatic Castration-Resistant Prostate Carcinoma; Metastatic Prostate Adenocarcinoma · MET

#MET#CGT#Phase2#cell-gene-therapy#CAR-T+4

CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

Anti-Tumor Necrosis Factor (TNF, Anti-Tumor Necrosis Factor, Anti-Tumor Necrosis Factor (TNF) Receptor Superfamily Member 8 (CD30) Chimeric Antigen Receptor (CAR) T cells)

Lymphoma, Large-Cell, Anaplastic; Enteropathy-Associated T-Cell Lymphoma · CD30

#CD30#CGT#Phase1#cell-gene-therapy#CAR-T+5

CGTLimited DatastaleRoswell Park Cancer InstitutePhase 1

Autologous Anti-CD83 CAR T-cells (Autologous Anti-CD83 CAR T-cells)

Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4

CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

Autologous CCR4 CAR T cells (Autologous CCR4 CAR T cells)

Relapsed and/or Refractory Mature T Cell Malignancy; Peripheral T-Cell Lymphoma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+5

CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

Autologous CD5 CAR T-cells (Autologous CD5 CAR T-cells)

T-Cell Acute Lymphocytic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · FRα

CGTLimited DatastaleBaylor College of MedicinePhase 1

Autologous CD5.CAR/28zeta CAR T cells (Autologous CD5.CAR/28zeta CAR T cells)

T-cell Acute Lymphoblastic Lymphoma; T-non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Lymphoma

#T-cellAcuteLymphoblasticLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3

CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

Autologous CD7 CAR T-cell (Autologous CD7 CAR T-cell)

T-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · FRα

CGTLimited DatastaleZhejiang UniversityPhase 1

BCMA Targeted CAR T-cells (BCMA Targeted CAR T-cells)

Relapse Multiple Myeloma; Refractory Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+4

CGTLimited DatastaleCells & Genes Biotech (Shanghai…Phase 1

BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell (BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell)

Relapsed/Refractory; Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+5

ADCLimited DatastaleSeagenPreclinical

brentuximab vedotin (Adcetris, Brentuximab Vedotin Plus CHP)

CD30-Positive Peripheral T-Cell Lymphoma · CD30

#CD30#ADC#Preclinical#antibody-drug-conjugate#CD30-PositivePeripheralT-CellLym+1

CGTLimited DatastaleGroupe Hospitalier Pitie-Salpet…Preclinical

CAR T-cell and Cellular Therapies (CAR T-cell and Cellular Therapies)

Adverse Drug Reactions; Cancer · Adverse Drug Reactions

#AdverseDrugReactions#CGT#Preclinical#cell-gene-therapy#CAR-T+3

CGTLimited DatastaleCARsgen Therapeutics Co., Ltd.Phase 1

CAR-CLDN18.2 T-Cells (CAR-CLDN18.2 T-Cells)

Advanced Solid Tumor · CLDN18.2

#CLDN182#CGT#Phase1#cell-gene-therapy#CAR-T+3

CGTLimited DatastaleUniversity College, LondonPhase 1

CAR19 T-Cells (CAR19 T-Cells)

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2

CGTLimited DatastaleGyala TherapeuticsPhase 2

CART84 (CART84)

Acute Myeloblastic Leukaemia; Leukemia, T-Cell · Acute Myeloblastic Leukaemia

#AcuteMyeloblasticLeukaemia#CGT#Phase2#cell-gene-therapy#CAR-T+4

CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

CD117 CAR T-cells (CD117 CAR T-cells)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2

CGTLimited DatastalePeking University People's Hosp…Phase 1

CD147- CAR T cells (CD147- CAR T cells)

T-cell Non-Hodgkin's Lymphoma · T-cell Non-Hodgkin's Lymphoma

#T-cellNon-HodgkinsLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2

CGTLimited DatastaleGuangdong Zhaotai Cell Bio-tech…Phase 2

CAT19T2 (CD19 CAR T-Cell, CD19 CAR T-Cell(CAT19T2))

B-cell Acute Lymphoblastic Leukemia; B-Cell Lymphoma, Unspecified · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+5

Trials 1Status Discontinued

CGTLimited DatastaleThird Military Medical Universi…Phase 1

CD19 CAR and PD-1 knock out engineered T-cells (CD19 CAR and PD-1 knock out engineered T-cells)

Acute Lymphoblastic Leukemia; Burkitt Lymphoma · PD-1

#PD-1#CGT#Phase1#cell-gene-therapy#CAR-T+4